Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:tomicm01

Total Results:

185


From enhancesome to repressosome: Molecular antagonism between corticosteroids and proinflammatory cytokines/growth factors [Meeting Abstract]

Tomic-Canic, M; Lee, B; Bender, H; Robinson, E
ISI:000170668300836
ISSN: 0022-202x
CID: 54908

Regulators of expression of K15 keratin gene promoter [Meeting Abstract]

Radoja, N; Tomic-Canic, M; Milisavljevic, V; Teebor, S; Rao, L; Freedberg, I; Blumenberg, M
ISI:000170668300173
ISSN: 0022-202x
CID: 54899

Transcriptional fine-tuning: The nuclear receptor's hierarchy in the regulation of keratin gene expression [Meeting Abstract]

Robinson, E; Lee, B; Bender, H; Tomic-Canic, M
ISI:000170668300824
ISSN: 0022-202x
CID: 54907

Keratins and the keratinocyte activation cycle

Freedberg IM; Tomic-Canic M; Komine M; Blumenberg M
In wound healing and many pathologic conditions, keratinocytes become activated: they turn into migratory, hyperproliferative cells that produce and secrete extracellular matrix components and signaling polypeptides. At the same time, their cytoskeleton is also altered by the production of specific keratin proteins. These changes are orchestrated by growth factors, chemokines, and cytokines produced by keratinocytes and other cutaneous cell types. The responding intracellular signaling pathways activate transcription factors that regulate expression of keratin genes. Analysis of these processes led us to propose the existence of a keratinocyte activation cycle, in which the cells first become activated by the release of IL-1. Subsequently, they maintain the activated state by autocrine production of proinflammatory and proliferative signals. Keratins K6 and K16 are markers of the active state. Signals from the lymphocytes, in the form of Interferon-gamma, induce the expression of K17 and make keratinocytes contractile. This enables the keratinocytes to shrink the provisional fibronectin-rich basement membrane. Signals from the fibroblasts, in the form of TGF-beta, induce the expression of K5 and K14, revert the keratinocytes to the healthy basal phenotype, and thus complete the activation cycle
PMID: 11348449
ISSN: 0022-202x
CID: 20670

Inflammatory versus proliferative processes in epidermis. Tumor necrosis factor alpha induces K6b keratin synthesis through a transcriptional complex containing NFkappa B and C/EBPbeta

Komine M; Rao LS; Kaneko T; Tomic-Canic M; Tamaki K; Freedberg IM; Blumenberg M
Epidermal keratinocytes respond to injury by becoming activated, i.e. hyperproliferative, migratory, and proinflammatory. These processes are regulated by growth factors and cytokines. One of the markers of activated keratinocytes is keratin K6. We used a novel organ culture system to show that tumor necrosis factor alpha (TNFalpha) induces the expression of K6 protein and mRNA in human skin. Multiple isoforms of K6 are encoded by distinct genes and have distinct patterns of expression. By having shown previously that proliferative signals, such as epidermal growth factor (EGF), induce expression of the cytoskeletal protein keratin K6b, we here demonstrate that the same isoform, K6b, is also induced by TNFalpha, a proinflammatory cytokine. Specifically, TNFalpha induces the transcription of the K6b gene promoter. By using co-transfection, specific inhibitors, and antisense oligonucleotides, we have identified NFkappaB and C/EBPbeta as the transcription factors that convey the TNFalpha signal. Both transcription factors are necessary for the induction of K6b by TNFalpha and act as a complex, although only C/EBPbeta binds the K6b promoter DNA. By using transfection, site-directed mutagenesis, and footprinting, we have mapped the site that responds to TNFalpha, NFkappaB, and C/EBPbeta. This site is separate from the one responsive to EGF and AP1. Our results show that the proinflammatory (TNFalpha) and the proliferative (EGF) signals in epidermis separately and independently regulate the expression of the same K6b keratin isoform. Thus, the cytoskeletal responses in epidermal cells can be precisely tuned by separate proliferative and inflammatory signals to fit the nature of the injuries that caused them
PMID: 10887174
ISSN: 0021-9258
CID: 16372

Novel mechanism of steroid action in skin through glucocorticoid receptor monomers

Radoja N; Komine M; Jho SH; Blumenberg M; Tomic-Canic M
Glucocorticoids (GCs), important regulators of epidermal growth, differentiation, and homeostasis, are used extensively in the treatment of skin diseases. Using keratin gene expression as a paradigm of epidermal physiology and pathology, we have developed a model system to study the molecular mechanism of GCs action in skin. Here we describe a novel mechanism of suppression of transcription by the glucocorticoid receptor (GR) that represents an example of customizing a device for transcriptional regulation to target a specific group of genes within the target tissue, in our case, epidermis. We have shown that GCs repress the expression of the basal-cell-specific keratins K5 and K14 and disease-associated keratins K6, K16, and K17 but not the differentiation-specific keratins K3 and K10 or the simple epithelium-specific keratins K8, K18, and K19. We have identified the negative recognition elements (nGREs) in all five regulated keratin gene promoters. Detailed footprinting revealed that the function of nGREs is to instruct the GR to bind as four monomers. Furthermore, using cotransfection and antisense technology we have found that, unlike SRC-1 and GRIP-1, which are not involved in the GR complex that suppresses keratin genes, histone acetyltransferase and CBP are. In addition, we have found that GR, independently from GREs, blocks the induction of keratin gene expression by AP1. We conclude that GR suppresses keratin gene expression through two independent mechanisms: directly, through interactions of keratin nGREs with four GR monomers, as well as indirectly, by blocking the AP1 induction of keratin gene expression
PMCID:85800
PMID: 10825196
ISSN: 0270-7306
CID: 11686

Reach in and touch a gene: The use of antisense reagents in culture, skin explants and by topical application targets transcription factors, signaling molecules and structural proteins

Tomic-Canic, M; Im, M; Long, W; Schuck, A; Hosein, N; Radoja, N; Delgado, Y B; Freedberg, I M; Blumenberg, M
BIOSIS:200000215749
ISSN: 0022-202x
CID: 15817

The book of opposites: Molecular mechanisms of glucocorticoid action in epidermis [Meeting Abstract]

Radoja, N; Jho, S; Im, M; Freedberg, I; Tomic-Canic, M
ISI:000079495800186
ISSN: 0022-202x
CID: 54080

Touching the untouchable: The use of antisense technology in skin [Meeting Abstract]

Freedberg, I; Blumenberg, M; Tomic-Canic, M
ISI:000079495800442
ISSN: 0022-202x
CID: 54084

Selective regulation of gene expression using rationally-modified retinoic acid receptors [16] [Letter]

Koh, JT; Putnam, M; Tomic-Canic, M; McDaniel, CM
SCOPUS:0033541082
ISSN: 0002-7863
CID: 637842